Published in Medical Letter on the CDC and FDA, June 14th, 2006
In a recent report published in the journal AIDS, researchers in the United States conducted a study to "examine the effect of repeated, long-cycle structured intermittent versus continuous HAART on health-related quality of life (HRQL) and symptom distress in patients with chronic HIV infection and plasma HIV RNA of less than 50 copies/mL."
A prospective "survey of adult patients (n=46) enrolled in a randomized clinical trial evaluating intermittent versus continuous HAART on immunological and virologic parameters" was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.